Press release
Malaria Treatment Market SWOT Analysis, Industry Revenue, Growth Overview, Industry Share And Forecast To 2032
Malaria Treatment Market
The Business Research Company's Malaria Treatment Global Market Report 2023 identifies high incidence of malaria as the major driver for the Malaria Treatment market's growth in the forecast period. Malaria refers to a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite, characterized by recurring fever and other flu-like symptoms. This shift has resulted from poverty, limited access to healthcare services, climate change, lack of malaria control measures, and drug resistance. Malaria treatment helps to effectively manage and cure the infection caused by the Plasmodium parasite.
The global malaria treatment market size is expected to grow from $1.42 billion in 2022 to $1.49 billion in 2023 at a compound annual growth rate (CAGR) of 4.77%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of malaria treatment market is expected to reach $1.82 billion in 2027 at a CAGR of 5.14%.
Download Free Sample Of Malaria Treatment Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp
Major competitors in the Malaria Treatment market are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Mylan N.V., Sandoz International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontieres (Doctors Without Borders), Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), Aprecia Pharmaceuticals LLC, AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, and Actiza Pharmaceutical Private Limited
A key trend in the Malaria Treatment market includes development of novel diagnostic technologies. Companies operating in the malaria treatment market are adopting novel diagnostic malaria detection technologies to sustain their position in the market.
Read More On The Global Malaria Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report
The Malaria Treatment market is segmented -
1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Middle East and Africa was the largest region in the Malaria Treatment market.
The Business Research Company's "Global Malaria Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Malaria Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11939
The Table Of Content For The Malaria Treatment Market Include:
1. Executive Summary
2. Malaria Treatment Market Characteristics
3. Malaria Treatment Market Trends And Strategies
4. Malaria Treatment Market - Macro Economic Scenario
5. Malaria Treatment Market Size And Growth
........
32. Global Malaria Treatment Market Competitive Benchmarking
33. Global Malaria Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Malaria Treatment Market
35. Malaria Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malaria Treatment Market SWOT Analysis, Industry Revenue, Growth Overview, Industry Share And Forecast To 2032 here
News-ID: 3218039 • Views: …
More Releases from The Business research company
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Malaria
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database.
Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional…
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in…
